MEI Pharma, Inc. announced the expansion of its management team with the addition of two experienced industry executives. Alejandro Ricart, M.D., joins MEI as senior vice president, clinical development, a role that will report to Richard Ghalie, M.D., chief medical officer, and Yomara Gomez-Naiden joins as senior vice president, quality, reporting to Daniel P. Gold, Ph.D., chief executive officer. Both appointments are effective immediately.

Most recently, Ricart was vice president of clinical development at TG Therapeutics. Previously, Ms. Gomez-Naiden served as vice president of corporate quality at AGC Biologics, where she led the establishment of the company's first Global Quality Management System and Corporate Quality Program.